Global Antibody-drug Conjugates Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Antibody-drug Conjugates market size was valued at US$ 3191 million in 2024 and is forecast to a readjusted size of USD 4354 million by 2031 with a CAGR of 4.6% during review period.
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.
The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.
This report is a detailed and comprehensive analysis for global Antibody-drug Conjugates market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antibody-drug Conjugates market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Antibody-drug Conjugates market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Antibody-drug Conjugates market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Antibody-drug Conjugates market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody-drug Conjugates
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody-drug Conjugates market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ImmunoGen, Seattle Genetics, Roche, Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Antibody-drug Conjugates market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody-drug Conjugates product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antibody-drug Conjugates, with price, sales quantity, revenue, and global market share of Antibody-drug Conjugates from 2020 to 2025.
Chapter 3, the Antibody-drug Conjugates competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody-drug Conjugates breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Antibody-drug Conjugates market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antibody-drug Conjugates.
Chapter 14 and 15, to describe Antibody-drug Conjugates sales channel, distributors, customers, research findings and conclusion.
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.
The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.
This report is a detailed and comprehensive analysis for global Antibody-drug Conjugates market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antibody-drug Conjugates market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Antibody-drug Conjugates market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Antibody-drug Conjugates market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Antibody-drug Conjugates market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody-drug Conjugates
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody-drug Conjugates market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ImmunoGen, Seattle Genetics, Roche, Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Antibody-drug Conjugates market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Adcetris
- Kadcyla
- Breast Cancer
- Lymphoma
- ImmunoGen
- Seattle Genetics
- Roche
- Takeda
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody-drug Conjugates product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antibody-drug Conjugates, with price, sales quantity, revenue, and global market share of Antibody-drug Conjugates from 2020 to 2025.
Chapter 3, the Antibody-drug Conjugates competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody-drug Conjugates breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Antibody-drug Conjugates market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antibody-drug Conjugates.
Chapter 14 and 15, to describe Antibody-drug Conjugates sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antibody-drug Conjugates Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Adcetris
1.3.3 Kadcyla
1.4 Market Analysis by Application
1.4.1 Overview: Global Antibody-drug Conjugates Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Breast Cancer
1.4.3 Lymphoma
1.5 Global Antibody-drug Conjugates Market Size & Forecast
1.5.1 Global Antibody-drug Conjugates Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Antibody-drug Conjugates Sales Quantity (2020-2031)
1.5.3 Global Antibody-drug Conjugates Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 ImmunoGen
2.1.1 ImmunoGen Details
2.1.2 ImmunoGen Major Business
2.1.3 ImmunoGen Antibody-drug Conjugates Product and Services
2.1.4 ImmunoGen Antibody-drug Conjugates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 ImmunoGen Recent Developments/Updates
2.2 Seattle Genetics
2.2.1 Seattle Genetics Details
2.2.2 Seattle Genetics Major Business
2.2.3 Seattle Genetics Antibody-drug Conjugates Product and Services
2.2.4 Seattle Genetics Antibody-drug Conjugates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Seattle Genetics Recent Developments/Updates
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Antibody-drug Conjugates Product and Services
2.3.4 Roche Antibody-drug Conjugates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Roche Recent Developments/Updates
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business
2.4.3 Takeda Antibody-drug Conjugates Product and Services
2.4.4 Takeda Antibody-drug Conjugates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Takeda Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTIBODY-DRUG CONJUGATES BY MANUFACTURER
3.1 Global Antibody-drug Conjugates Sales Quantity by Manufacturer (2020-2025)
3.2 Global Antibody-drug Conjugates Revenue by Manufacturer (2020-2025)
3.3 Global Antibody-drug Conjugates Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Antibody-drug Conjugates by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Antibody-drug Conjugates Manufacturer Market Share in 2024
3.4.3 Top 6 Antibody-drug Conjugates Manufacturer Market Share in 2024
3.5 Antibody-drug Conjugates Market: Overall Company Footprint Analysis
3.5.1 Antibody-drug Conjugates Market: Region Footprint
3.5.2 Antibody-drug Conjugates Market: Company Product Type Footprint
3.5.3 Antibody-drug Conjugates Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Antibody-drug Conjugates Market Size by Region
4.1.1 Global Antibody-drug Conjugates Sales Quantity by Region (2020-2031)
4.1.2 Global Antibody-drug Conjugates Consumption Value by Region (2020-2031)
4.1.3 Global Antibody-drug Conjugates Average Price by Region (2020-2031)
4.2 North America Antibody-drug Conjugates Consumption Value (2020-2031)
4.3 Europe Antibody-drug Conjugates Consumption Value (2020-2031)
4.4 Asia-Pacific Antibody-drug Conjugates Consumption Value (2020-2031)
4.5 South America Antibody-drug Conjugates Consumption Value (2020-2031)
4.6 Middle East & Africa Antibody-drug Conjugates Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
5.2 Global Antibody-drug Conjugates Consumption Value by Type (2020-2031)
5.3 Global Antibody-drug Conjugates Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
6.2 Global Antibody-drug Conjugates Consumption Value by Application (2020-2031)
6.3 Global Antibody-drug Conjugates Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
7.2 North America Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
7.3 North America Antibody-drug Conjugates Market Size by Country
7.3.1 North America Antibody-drug Conjugates Sales Quantity by Country (2020-2031)
7.3.2 North America Antibody-drug Conjugates Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
8.2 Europe Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
8.3 Europe Antibody-drug Conjugates Market Size by Country
8.3.1 Europe Antibody-drug Conjugates Sales Quantity by Country (2020-2031)
8.3.2 Europe Antibody-drug Conjugates Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Antibody-drug Conjugates Market Size by Region
9.3.1 Asia-Pacific Antibody-drug Conjugates Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Antibody-drug Conjugates Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
10.2 South America Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
10.3 South America Antibody-drug Conjugates Market Size by Country
10.3.1 South America Antibody-drug Conjugates Sales Quantity by Country (2020-2031)
10.3.2 South America Antibody-drug Conjugates Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Antibody-drug Conjugates Market Size by Country
11.3.1 Middle East & Africa Antibody-drug Conjugates Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Antibody-drug Conjugates Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Antibody-drug Conjugates Market Drivers
12.2 Antibody-drug Conjugates Market Restraints
12.3 Antibody-drug Conjugates Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Antibody-drug Conjugates and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antibody-drug Conjugates
13.3 Antibody-drug Conjugates Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antibody-drug Conjugates Typical Distributors
14.3 Antibody-drug Conjugates Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antibody-drug Conjugates Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Adcetris
1.3.3 Kadcyla
1.4 Market Analysis by Application
1.4.1 Overview: Global Antibody-drug Conjugates Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Breast Cancer
1.4.3 Lymphoma
1.5 Global Antibody-drug Conjugates Market Size & Forecast
1.5.1 Global Antibody-drug Conjugates Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Antibody-drug Conjugates Sales Quantity (2020-2031)
1.5.3 Global Antibody-drug Conjugates Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 ImmunoGen
2.1.1 ImmunoGen Details
2.1.2 ImmunoGen Major Business
2.1.3 ImmunoGen Antibody-drug Conjugates Product and Services
2.1.4 ImmunoGen Antibody-drug Conjugates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 ImmunoGen Recent Developments/Updates
2.2 Seattle Genetics
2.2.1 Seattle Genetics Details
2.2.2 Seattle Genetics Major Business
2.2.3 Seattle Genetics Antibody-drug Conjugates Product and Services
2.2.4 Seattle Genetics Antibody-drug Conjugates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Seattle Genetics Recent Developments/Updates
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Antibody-drug Conjugates Product and Services
2.3.4 Roche Antibody-drug Conjugates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Roche Recent Developments/Updates
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business
2.4.3 Takeda Antibody-drug Conjugates Product and Services
2.4.4 Takeda Antibody-drug Conjugates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Takeda Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTIBODY-DRUG CONJUGATES BY MANUFACTURER
3.1 Global Antibody-drug Conjugates Sales Quantity by Manufacturer (2020-2025)
3.2 Global Antibody-drug Conjugates Revenue by Manufacturer (2020-2025)
3.3 Global Antibody-drug Conjugates Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Antibody-drug Conjugates by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Antibody-drug Conjugates Manufacturer Market Share in 2024
3.4.3 Top 6 Antibody-drug Conjugates Manufacturer Market Share in 2024
3.5 Antibody-drug Conjugates Market: Overall Company Footprint Analysis
3.5.1 Antibody-drug Conjugates Market: Region Footprint
3.5.2 Antibody-drug Conjugates Market: Company Product Type Footprint
3.5.3 Antibody-drug Conjugates Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Antibody-drug Conjugates Market Size by Region
4.1.1 Global Antibody-drug Conjugates Sales Quantity by Region (2020-2031)
4.1.2 Global Antibody-drug Conjugates Consumption Value by Region (2020-2031)
4.1.3 Global Antibody-drug Conjugates Average Price by Region (2020-2031)
4.2 North America Antibody-drug Conjugates Consumption Value (2020-2031)
4.3 Europe Antibody-drug Conjugates Consumption Value (2020-2031)
4.4 Asia-Pacific Antibody-drug Conjugates Consumption Value (2020-2031)
4.5 South America Antibody-drug Conjugates Consumption Value (2020-2031)
4.6 Middle East & Africa Antibody-drug Conjugates Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
5.2 Global Antibody-drug Conjugates Consumption Value by Type (2020-2031)
5.3 Global Antibody-drug Conjugates Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
6.2 Global Antibody-drug Conjugates Consumption Value by Application (2020-2031)
6.3 Global Antibody-drug Conjugates Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
7.2 North America Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
7.3 North America Antibody-drug Conjugates Market Size by Country
7.3.1 North America Antibody-drug Conjugates Sales Quantity by Country (2020-2031)
7.3.2 North America Antibody-drug Conjugates Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
8.2 Europe Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
8.3 Europe Antibody-drug Conjugates Market Size by Country
8.3.1 Europe Antibody-drug Conjugates Sales Quantity by Country (2020-2031)
8.3.2 Europe Antibody-drug Conjugates Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Antibody-drug Conjugates Market Size by Region
9.3.1 Asia-Pacific Antibody-drug Conjugates Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Antibody-drug Conjugates Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
10.2 South America Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
10.3 South America Antibody-drug Conjugates Market Size by Country
10.3.1 South America Antibody-drug Conjugates Sales Quantity by Country (2020-2031)
10.3.2 South America Antibody-drug Conjugates Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Antibody-drug Conjugates Market Size by Country
11.3.1 Middle East & Africa Antibody-drug Conjugates Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Antibody-drug Conjugates Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Antibody-drug Conjugates Market Drivers
12.2 Antibody-drug Conjugates Market Restraints
12.3 Antibody-drug Conjugates Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Antibody-drug Conjugates and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antibody-drug Conjugates
13.3 Antibody-drug Conjugates Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antibody-drug Conjugates Typical Distributors
14.3 Antibody-drug Conjugates Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Antibody-drug Conjugates Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Antibody-drug Conjugates Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. ImmunoGen Basic Information, Manufacturing Base and Competitors
Table 4. ImmunoGen Major Business
Table 5. ImmunoGen Antibody-drug Conjugates Product and Services
Table 6. ImmunoGen Antibody-drug Conjugates Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. ImmunoGen Recent Developments/Updates
Table 8. Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table 9. Seattle Genetics Major Business
Table 10. Seattle Genetics Antibody-drug Conjugates Product and Services
Table 11. Seattle Genetics Antibody-drug Conjugates Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Seattle Genetics Recent Developments/Updates
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche Major Business
Table 15. Roche Antibody-drug Conjugates Product and Services
Table 16. Roche Antibody-drug Conjugates Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Roche Recent Developments/Updates
Table 18. Takeda Basic Information, Manufacturing Base and Competitors
Table 19. Takeda Major Business
Table 20. Takeda Antibody-drug Conjugates Product and Services
Table 21. Takeda Antibody-drug Conjugates Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Takeda Recent Developments/Updates
Table 23. Global Antibody-drug Conjugates Sales Quantity by Manufacturer (2020-2025) & (Kg)
Table 24. Global Antibody-drug Conjugates Revenue by Manufacturer (2020-2025) & (USD Million)
Table 25. Global Antibody-drug Conjugates Average Price by Manufacturer (2020-2025) & (USD/Kg)
Table 26. Market Position of Manufacturers in Antibody-drug Conjugates, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 27. Head Office and Antibody-drug Conjugates Production Site of Key Manufacturer
Table 28. Antibody-drug Conjugates Market: Company Product Type Footprint
Table 29. Antibody-drug Conjugates Market: Company Product Application Footprint
Table 30. Antibody-drug Conjugates New Market Entrants and Barriers to Market Entry
Table 31. Antibody-drug Conjugates Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Antibody-drug Conjugates Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 33. Global Antibody-drug Conjugates Sales Quantity by Region (2020-2025) & (Kg)
Table 34. Global Antibody-drug Conjugates Sales Quantity by Region (2026-2031) & (Kg)
Table 35. Global Antibody-drug Conjugates Consumption Value by Region (2020-2025) & (USD Million)
Table 36. Global Antibody-drug Conjugates Consumption Value by Region (2026-2031) & (USD Million)
Table 37. Global Antibody-drug Conjugates Average Price by Region (2020-2025) & (USD/Kg)
Table 38. Global Antibody-drug Conjugates Average Price by Region (2026-2031) & (USD/Kg)
Table 39. Global Antibody-drug Conjugates Sales Quantity by Type (2020-2025) & (Kg)
Table 40. Global Antibody-drug Conjugates Sales Quantity by Type (2026-2031) & (Kg)
Table 41. Global Antibody-drug Conjugates Consumption Value by Type (2020-2025) & (USD Million)
Table 42. Global Antibody-drug Conjugates Consumption Value by Type (2026-2031) & (USD Million)
Table 43. Global Antibody-drug Conjugates Average Price by Type (2020-2025) & (USD/Kg)
Table 44. Global Antibody-drug Conjugates Average Price by Type (2026-2031) & (USD/Kg)
Table 45. Global Antibody-drug Conjugates Sales Quantity by Application (2020-2025) & (Kg)
Table 46. Global Antibody-drug Conjugates Sales Quantity by Application (2026-2031) & (Kg)
Table 47. Global Antibody-drug Conjugates Consumption Value by Application (2020-2025) & (USD Million)
Table 48. Global Antibody-drug Conjugates Consumption Value by Application (2026-2031) & (USD Million)
Table 49. Global Antibody-drug Conjugates Average Price by Application (2020-2025) & (USD/Kg)
Table 50. Global Antibody-drug Conjugates Average Price by Application (2026-2031) & (USD/Kg)
Table 51. North America Antibody-drug Conjugates Sales Quantity by Type (2020-2025) & (Kg)
Table 52. North America Antibody-drug Conjugates Sales Quantity by Type (2026-2031) & (Kg)
Table 53. North America Antibody-drug Conjugates Sales Quantity by Application (2020-2025) & (Kg)
Table 54. North America Antibody-drug Conjugates Sales Quantity by Application (2026-2031) & (Kg)
Table 55. North America Antibody-drug Conjugates Sales Quantity by Country (2020-2025) & (Kg)
Table 56. North America Antibody-drug Conjugates Sales Quantity by Country (2026-2031) & (Kg)
Table 57. North America Antibody-drug Conjugates Consumption Value by Country (2020-2025) & (USD Million)
Table 58. North America Antibody-drug Conjugates Consumption Value by Country (2026-2031) & (USD Million)
Table 59. Europe Antibody-drug Conjugates Sales Quantity by Type (2020-2025) & (Kg)
Table 60. Europe Antibody-drug Conjugates Sales Quantity by Type (2026-2031) & (Kg)
Table 61. Europe Antibody-drug Conjugates Sales Quantity by Application (2020-2025) & (Kg)
Table 62. Europe Antibody-drug Conjugates Sales Quantity by Application (2026-2031) & (Kg)
Table 63. Europe Antibody-drug Conjugates Sales Quantity by Country (2020-2025) & (Kg)
Table 64. Europe Antibody-drug Conjugates Sales Quantity by Country (2026-2031) & (Kg)
Table 65. Europe Antibody-drug Conjugates Consumption Value by Country (2020-2025) & (USD Million)
Table 66. Europe Antibody-drug Conjugates Consumption Value by Country (2026-2031) & (USD Million)
Table 67. Asia-Pacific Antibody-drug Conjugates Sales Quantity by Type (2020-2025) & (Kg)
Table 68. Asia-Pacific Antibody-drug Conjugates Sales Quantity by Type (2026-2031) & (Kg)
Table 69. Asia-Pacific Antibody-drug Conjugates Sales Quantity by Application (2020-2025) & (Kg)
Table 70. Asia-Pacific Antibody-drug Conjugates Sales Quantity by Application (2026-2031) & (Kg)
Table 71. Asia-Pacific Antibody-drug Conjugates Sales Quantity by Region (2020-2025) & (Kg)
Table 72. Asia-Pacific Antibody-drug Conjugates Sales Quantity by Region (2026-2031) & (Kg)
Table 73. Asia-Pacific Antibody-drug Conjugates Consumption Value by Region (2020-2025) & (USD Million)
Table 74. Asia-Pacific Antibody-drug Conjugates Consumption Value by Region (2026-2031) & (USD Million)
Table 75. South America Antibody-drug Conjugates Sales Quantity by Type (2020-2025) & (Kg)
Table 76. South America Antibody-drug Conjugates Sales Quantity by Type (2026-2031) & (Kg)
Table 77. South America Antibody-drug Conjugates Sales Quantity by Application (2020-2025) & (Kg)
Table 78. South America Antibody-drug Conjugates Sales Quantity by Application (2026-2031) & (Kg)
Table 79. South America Antibody-drug Conjugates Sales Quantity by Country (2020-2025) & (Kg)
Table 80. South America Antibody-drug Conjugates Sales Quantity by Country (2026-2031) & (Kg)
Table 81. South America Antibody-drug Conjugates Consumption Value by Country (2020-2025) & (USD Million)
Table 82. South America Antibody-drug Conjugates Consumption Value by Country (2026-2031) & (USD Million)
Table 83. Middle East & Africa Antibody-drug Conjugates Sales Quantity by Type (2020-2025) & (Kg)
Table 84. Middle East & Africa Antibody-drug Conjugates Sales Quantity by Type (2026-2031) & (Kg)
Table 85. Middle East & Africa Antibody-drug Conjugates Sales Quantity by Application (2020-2025) & (Kg)
Table 86. Middle East & Africa Antibody-drug Conjugates Sales Quantity by Application (2026-2031) & (Kg)
Table 87. Middle East & Africa Antibody-drug Conjugates Sales Quantity by Country (2020-2025) & (Kg)
Table 88. Middle East & Africa Antibody-drug Conjugates Sales Quantity by Country (2026-2031) & (Kg)
Table 89. Middle East & Africa Antibody-drug Conjugates Consumption Value by Country (2020-2025) & (USD Million)
Table 90. Middle East & Africa Antibody-drug Conjugates Consumption Value by Country (2026-2031) & (USD Million)
Table 91. Antibody-drug Conjugates Raw Material
Table 92. Key Manufacturers of Antibody-drug Conjugates Raw Materials
Table 93. Antibody-drug Conjugates Typical Distributors
Table 94. Antibody-drug Conjugates Typical Customers
Table 1. Global Antibody-drug Conjugates Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Antibody-drug Conjugates Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. ImmunoGen Basic Information, Manufacturing Base and Competitors
Table 4. ImmunoGen Major Business
Table 5. ImmunoGen Antibody-drug Conjugates Product and Services
Table 6. ImmunoGen Antibody-drug Conjugates Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. ImmunoGen Recent Developments/Updates
Table 8. Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table 9. Seattle Genetics Major Business
Table 10. Seattle Genetics Antibody-drug Conjugates Product and Services
Table 11. Seattle Genetics Antibody-drug Conjugates Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Seattle Genetics Recent Developments/Updates
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche Major Business
Table 15. Roche Antibody-drug Conjugates Product and Services
Table 16. Roche Antibody-drug Conjugates Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Roche Recent Developments/Updates
Table 18. Takeda Basic Information, Manufacturing Base and Competitors
Table 19. Takeda Major Business
Table 20. Takeda Antibody-drug Conjugates Product and Services
Table 21. Takeda Antibody-drug Conjugates Sales Quantity (Kg), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Takeda Recent Developments/Updates
Table 23. Global Antibody-drug Conjugates Sales Quantity by Manufacturer (2020-2025) & (Kg)
Table 24. Global Antibody-drug Conjugates Revenue by Manufacturer (2020-2025) & (USD Million)
Table 25. Global Antibody-drug Conjugates Average Price by Manufacturer (2020-2025) & (USD/Kg)
Table 26. Market Position of Manufacturers in Antibody-drug Conjugates, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 27. Head Office and Antibody-drug Conjugates Production Site of Key Manufacturer
Table 28. Antibody-drug Conjugates Market: Company Product Type Footprint
Table 29. Antibody-drug Conjugates Market: Company Product Application Footprint
Table 30. Antibody-drug Conjugates New Market Entrants and Barriers to Market Entry
Table 31. Antibody-drug Conjugates Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Antibody-drug Conjugates Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 33. Global Antibody-drug Conjugates Sales Quantity by Region (2020-2025) & (Kg)
Table 34. Global Antibody-drug Conjugates Sales Quantity by Region (2026-2031) & (Kg)
Table 35. Global Antibody-drug Conjugates Consumption Value by Region (2020-2025) & (USD Million)
Table 36. Global Antibody-drug Conjugates Consumption Value by Region (2026-2031) & (USD Million)
Table 37. Global Antibody-drug Conjugates Average Price by Region (2020-2025) & (USD/Kg)
Table 38. Global Antibody-drug Conjugates Average Price by Region (2026-2031) & (USD/Kg)
Table 39. Global Antibody-drug Conjugates Sales Quantity by Type (2020-2025) & (Kg)
Table 40. Global Antibody-drug Conjugates Sales Quantity by Type (2026-2031) & (Kg)
Table 41. Global Antibody-drug Conjugates Consumption Value by Type (2020-2025) & (USD Million)
Table 42. Global Antibody-drug Conjugates Consumption Value by Type (2026-2031) & (USD Million)
Table 43. Global Antibody-drug Conjugates Average Price by Type (2020-2025) & (USD/Kg)
Table 44. Global Antibody-drug Conjugates Average Price by Type (2026-2031) & (USD/Kg)
Table 45. Global Antibody-drug Conjugates Sales Quantity by Application (2020-2025) & (Kg)
Table 46. Global Antibody-drug Conjugates Sales Quantity by Application (2026-2031) & (Kg)
Table 47. Global Antibody-drug Conjugates Consumption Value by Application (2020-2025) & (USD Million)
Table 48. Global Antibody-drug Conjugates Consumption Value by Application (2026-2031) & (USD Million)
Table 49. Global Antibody-drug Conjugates Average Price by Application (2020-2025) & (USD/Kg)
Table 50. Global Antibody-drug Conjugates Average Price by Application (2026-2031) & (USD/Kg)
Table 51. North America Antibody-drug Conjugates Sales Quantity by Type (2020-2025) & (Kg)
Table 52. North America Antibody-drug Conjugates Sales Quantity by Type (2026-2031) & (Kg)
Table 53. North America Antibody-drug Conjugates Sales Quantity by Application (2020-2025) & (Kg)
Table 54. North America Antibody-drug Conjugates Sales Quantity by Application (2026-2031) & (Kg)
Table 55. North America Antibody-drug Conjugates Sales Quantity by Country (2020-2025) & (Kg)
Table 56. North America Antibody-drug Conjugates Sales Quantity by Country (2026-2031) & (Kg)
Table 57. North America Antibody-drug Conjugates Consumption Value by Country (2020-2025) & (USD Million)
Table 58. North America Antibody-drug Conjugates Consumption Value by Country (2026-2031) & (USD Million)
Table 59. Europe Antibody-drug Conjugates Sales Quantity by Type (2020-2025) & (Kg)
Table 60. Europe Antibody-drug Conjugates Sales Quantity by Type (2026-2031) & (Kg)
Table 61. Europe Antibody-drug Conjugates Sales Quantity by Application (2020-2025) & (Kg)
Table 62. Europe Antibody-drug Conjugates Sales Quantity by Application (2026-2031) & (Kg)
Table 63. Europe Antibody-drug Conjugates Sales Quantity by Country (2020-2025) & (Kg)
Table 64. Europe Antibody-drug Conjugates Sales Quantity by Country (2026-2031) & (Kg)
Table 65. Europe Antibody-drug Conjugates Consumption Value by Country (2020-2025) & (USD Million)
Table 66. Europe Antibody-drug Conjugates Consumption Value by Country (2026-2031) & (USD Million)
Table 67. Asia-Pacific Antibody-drug Conjugates Sales Quantity by Type (2020-2025) & (Kg)
Table 68. Asia-Pacific Antibody-drug Conjugates Sales Quantity by Type (2026-2031) & (Kg)
Table 69. Asia-Pacific Antibody-drug Conjugates Sales Quantity by Application (2020-2025) & (Kg)
Table 70. Asia-Pacific Antibody-drug Conjugates Sales Quantity by Application (2026-2031) & (Kg)
Table 71. Asia-Pacific Antibody-drug Conjugates Sales Quantity by Region (2020-2025) & (Kg)
Table 72. Asia-Pacific Antibody-drug Conjugates Sales Quantity by Region (2026-2031) & (Kg)
Table 73. Asia-Pacific Antibody-drug Conjugates Consumption Value by Region (2020-2025) & (USD Million)
Table 74. Asia-Pacific Antibody-drug Conjugates Consumption Value by Region (2026-2031) & (USD Million)
Table 75. South America Antibody-drug Conjugates Sales Quantity by Type (2020-2025) & (Kg)
Table 76. South America Antibody-drug Conjugates Sales Quantity by Type (2026-2031) & (Kg)
Table 77. South America Antibody-drug Conjugates Sales Quantity by Application (2020-2025) & (Kg)
Table 78. South America Antibody-drug Conjugates Sales Quantity by Application (2026-2031) & (Kg)
Table 79. South America Antibody-drug Conjugates Sales Quantity by Country (2020-2025) & (Kg)
Table 80. South America Antibody-drug Conjugates Sales Quantity by Country (2026-2031) & (Kg)
Table 81. South America Antibody-drug Conjugates Consumption Value by Country (2020-2025) & (USD Million)
Table 82. South America Antibody-drug Conjugates Consumption Value by Country (2026-2031) & (USD Million)
Table 83. Middle East & Africa Antibody-drug Conjugates Sales Quantity by Type (2020-2025) & (Kg)
Table 84. Middle East & Africa Antibody-drug Conjugates Sales Quantity by Type (2026-2031) & (Kg)
Table 85. Middle East & Africa Antibody-drug Conjugates Sales Quantity by Application (2020-2025) & (Kg)
Table 86. Middle East & Africa Antibody-drug Conjugates Sales Quantity by Application (2026-2031) & (Kg)
Table 87. Middle East & Africa Antibody-drug Conjugates Sales Quantity by Country (2020-2025) & (Kg)
Table 88. Middle East & Africa Antibody-drug Conjugates Sales Quantity by Country (2026-2031) & (Kg)
Table 89. Middle East & Africa Antibody-drug Conjugates Consumption Value by Country (2020-2025) & (USD Million)
Table 90. Middle East & Africa Antibody-drug Conjugates Consumption Value by Country (2026-2031) & (USD Million)
Table 91. Antibody-drug Conjugates Raw Material
Table 92. Key Manufacturers of Antibody-drug Conjugates Raw Materials
Table 93. Antibody-drug Conjugates Typical Distributors
Table 94. Antibody-drug Conjugates Typical Customers
LIST OF FIGURES
Figure 1. Antibody-drug Conjugates Picture
Figure 2. Global Antibody-drug Conjugates Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Antibody-drug Conjugates Revenue Market Share by Type in 2024
Figure 4. Adcetris Examples
Figure 5. Kadcyla Examples
Figure 6. Global Antibody-drug Conjugates Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Antibody-drug Conjugates Revenue Market Share by Application in 2024
Figure 8. Breast Cancer Examples
Figure 9. Lymphoma Examples
Figure 10. Global Antibody-drug Conjugates Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global Antibody-drug Conjugates Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Antibody-drug Conjugates Sales Quantity (2020-2031) & (Kg)
Figure 13. Global Antibody-drug Conjugates Price (2020-2031) & (USD/Kg)
Figure 14. Global Antibody-drug Conjugates Sales Quantity Market Share by Manufacturer in 2024
Figure 15. Global Antibody-drug Conjugates Revenue Market Share by Manufacturer in 2024
Figure 16. Producer Shipments of Antibody-drug Conjugates by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 17. Top 3 Antibody-drug Conjugates Manufacturer (Revenue) Market Share in 2024
Figure 18. Top 6 Antibody-drug Conjugates Manufacturer (Revenue) Market Share in 2024
Figure 19. Global Antibody-drug Conjugates Sales Quantity Market Share by Region (2020-2031)
Figure 20. Global Antibody-drug Conjugates Consumption Value Market Share by Region (2020-2031)
Figure 21. North America Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 22. Europe Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 23. Asia-Pacific Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 24. South America Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 25. Middle East & Africa Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 26. Global Antibody-drug Conjugates Sales Quantity Market Share by Type (2020-2031)
Figure 27. Global Antibody-drug Conjugates Consumption Value Market Share by Type (2020-2031)
Figure 28. Global Antibody-drug Conjugates Average Price by Type (2020-2031) & (USD/Kg)
Figure 29. Global Antibody-drug Conjugates Sales Quantity Market Share by Application (2020-2031)
Figure 30. Global Antibody-drug Conjugates Revenue Market Share by Application (2020-2031)
Figure 31. Global Antibody-drug Conjugates Average Price by Application (2020-2031) & (USD/Kg)
Figure 32. North America Antibody-drug Conjugates Sales Quantity Market Share by Type (2020-2031)
Figure 33. North America Antibody-drug Conjugates Sales Quantity Market Share by Application (2020-2031)
Figure 34. North America Antibody-drug Conjugates Sales Quantity Market Share by Country (2020-2031)
Figure 35. North America Antibody-drug Conjugates Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Antibody-drug Conjugates Sales Quantity Market Share by Type (2020-2031)
Figure 40. Europe Antibody-drug Conjugates Sales Quantity Market Share by Application (2020-2031)
Figure 41. Europe Antibody-drug Conjugates Sales Quantity Market Share by Country (2020-2031)
Figure 42. Europe Antibody-drug Conjugates Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 44. France Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Antibody-drug Conjugates Sales Quantity Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Antibody-drug Conjugates Sales Quantity Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Antibody-drug Conjugates Sales Quantity Market Share by Region (2020-2031)
Figure 51. Asia-Pacific Antibody-drug Conjugates Consumption Value Market Share by Region (2020-2031)
Figure 52. China Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 55. India Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Antibody-drug Conjugates Sales Quantity Market Share by Type (2020-2031)
Figure 59. South America Antibody-drug Conjugates Sales Quantity Market Share by Application (2020-2031)
Figure 60. South America Antibody-drug Conjugates Sales Quantity Market Share by Country (2020-2031)
Figure 61. South America Antibody-drug Conjugates Consumption Value Market Share by Country (2020-2031)
Figure 62. Brazil Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 63. Argentina Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 64. Middle East & Africa Antibody-drug Conjugates Sales Quantity Market Share by Type (2020-2031)
Figure 65. Middle East & Africa Antibody-drug Conjugates Sales Quantity Market Share by Application (2020-2031)
Figure 66. Middle East & Africa Antibody-drug Conjugates Sales Quantity Market Share by Country (2020-2031)
Figure 67. Middle East & Africa Antibody-drug Conjugates Consumption Value Market Share by Country (2020-2031)
Figure 68. Turkey Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 69. Egypt Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 70. Saudi Arabia Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 71. South Africa Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 72. Antibody-drug Conjugates Market Drivers
Figure 73. Antibody-drug Conjugates Market Restraints
Figure 74. Antibody-drug Conjugates Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Antibody-drug Conjugates in 2024
Figure 77. Manufacturing Process Analysis of Antibody-drug Conjugates
Figure 78. Antibody-drug Conjugates Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Antibody-drug Conjugates Picture
Figure 2. Global Antibody-drug Conjugates Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Antibody-drug Conjugates Revenue Market Share by Type in 2024
Figure 4. Adcetris Examples
Figure 5. Kadcyla Examples
Figure 6. Global Antibody-drug Conjugates Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Antibody-drug Conjugates Revenue Market Share by Application in 2024
Figure 8. Breast Cancer Examples
Figure 9. Lymphoma Examples
Figure 10. Global Antibody-drug Conjugates Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global Antibody-drug Conjugates Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Antibody-drug Conjugates Sales Quantity (2020-2031) & (Kg)
Figure 13. Global Antibody-drug Conjugates Price (2020-2031) & (USD/Kg)
Figure 14. Global Antibody-drug Conjugates Sales Quantity Market Share by Manufacturer in 2024
Figure 15. Global Antibody-drug Conjugates Revenue Market Share by Manufacturer in 2024
Figure 16. Producer Shipments of Antibody-drug Conjugates by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 17. Top 3 Antibody-drug Conjugates Manufacturer (Revenue) Market Share in 2024
Figure 18. Top 6 Antibody-drug Conjugates Manufacturer (Revenue) Market Share in 2024
Figure 19. Global Antibody-drug Conjugates Sales Quantity Market Share by Region (2020-2031)
Figure 20. Global Antibody-drug Conjugates Consumption Value Market Share by Region (2020-2031)
Figure 21. North America Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 22. Europe Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 23. Asia-Pacific Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 24. South America Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 25. Middle East & Africa Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 26. Global Antibody-drug Conjugates Sales Quantity Market Share by Type (2020-2031)
Figure 27. Global Antibody-drug Conjugates Consumption Value Market Share by Type (2020-2031)
Figure 28. Global Antibody-drug Conjugates Average Price by Type (2020-2031) & (USD/Kg)
Figure 29. Global Antibody-drug Conjugates Sales Quantity Market Share by Application (2020-2031)
Figure 30. Global Antibody-drug Conjugates Revenue Market Share by Application (2020-2031)
Figure 31. Global Antibody-drug Conjugates Average Price by Application (2020-2031) & (USD/Kg)
Figure 32. North America Antibody-drug Conjugates Sales Quantity Market Share by Type (2020-2031)
Figure 33. North America Antibody-drug Conjugates Sales Quantity Market Share by Application (2020-2031)
Figure 34. North America Antibody-drug Conjugates Sales Quantity Market Share by Country (2020-2031)
Figure 35. North America Antibody-drug Conjugates Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Antibody-drug Conjugates Sales Quantity Market Share by Type (2020-2031)
Figure 40. Europe Antibody-drug Conjugates Sales Quantity Market Share by Application (2020-2031)
Figure 41. Europe Antibody-drug Conjugates Sales Quantity Market Share by Country (2020-2031)
Figure 42. Europe Antibody-drug Conjugates Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 44. France Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Antibody-drug Conjugates Sales Quantity Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Antibody-drug Conjugates Sales Quantity Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Antibody-drug Conjugates Sales Quantity Market Share by Region (2020-2031)
Figure 51. Asia-Pacific Antibody-drug Conjugates Consumption Value Market Share by Region (2020-2031)
Figure 52. China Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 55. India Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Antibody-drug Conjugates Sales Quantity Market Share by Type (2020-2031)
Figure 59. South America Antibody-drug Conjugates Sales Quantity Market Share by Application (2020-2031)
Figure 60. South America Antibody-drug Conjugates Sales Quantity Market Share by Country (2020-2031)
Figure 61. South America Antibody-drug Conjugates Consumption Value Market Share by Country (2020-2031)
Figure 62. Brazil Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 63. Argentina Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 64. Middle East & Africa Antibody-drug Conjugates Sales Quantity Market Share by Type (2020-2031)
Figure 65. Middle East & Africa Antibody-drug Conjugates Sales Quantity Market Share by Application (2020-2031)
Figure 66. Middle East & Africa Antibody-drug Conjugates Sales Quantity Market Share by Country (2020-2031)
Figure 67. Middle East & Africa Antibody-drug Conjugates Consumption Value Market Share by Country (2020-2031)
Figure 68. Turkey Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 69. Egypt Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 70. Saudi Arabia Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 71. South Africa Antibody-drug Conjugates Consumption Value (2020-2031) & (USD Million)
Figure 72. Antibody-drug Conjugates Market Drivers
Figure 73. Antibody-drug Conjugates Market Restraints
Figure 74. Antibody-drug Conjugates Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Antibody-drug Conjugates in 2024
Figure 77. Manufacturing Process Analysis of Antibody-drug Conjugates
Figure 78. Antibody-drug Conjugates Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
